FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2062360412> ?p ?o ?g. }

• W2062360412 endingPage "177" @default.
• W2062360412 startingPage "172" @default.
• W2062360412 abstract "Abstract Background Nearly all patients with malignant glioma will have disease recurrence. Our purpose was to define the treatment toxicity and efficacy of concurrent bevazicumab (BVZ) with hypofractionated stereotactic radiosurgery (SRS) of relatively larger targets for patients with recurrent MG. Methods A retrospective review of 21 patients with recurrent malignant glioma (18 glioblastoma, 3 WHO grade III glioma), treated at initial diagnosis with surgery and standard chemoradiation, was performed. All patients had concurrent BVZ with hypofractionatedSRS, 30 Gy in 5 fractions, with or without concurrent chemotherapy (temozolomide or CCNU). Results Median patient age was 54 years, median Karnofsky Performance Status was 80, and median target size was 4.3 cm (range, 3.4–7.5 cm). Eleven patients (52%) had previously failed BVZ. One patient had grade 3 toxicities (seizures, dysphasia), which resolved with inpatient admission and intravenous steroids/antiepileptics. Treatment-related toxicities were grade 3 (n = 1), grade 2 (n = 9), and grade 0–1 (n = 11). Kaplan-Meier median progression-free survival and overall survival estimates (calculated from start of SRS) for GBM patients (n = 18) were 11.0 and 12.5 months, respectively. Concurrent chemotherapy did not appear to show any statistically significant efficacy benefit or have any propensity for toxicity. Conclusion BVZ concurrent with hypofractionated SRS was well tolerated by this cohort of patients with relatively larger targets. Ongoing randomized trials with more moderate radiotherapy dosing may help establish the efficacy of this regimen, though intricacies of this approach, including patient selection, radiation target volume delineation/size, and optimal radiation dose, will need further evaluation." @default.
• W2062360412 created "2016-06-24" @default.
• W2062360412 creator A5001717156 @default.
• W2062360412 creator A5059491130 @default.
• W2062360412 creator A5064668787 @default.
• W2062360412 creator A5066841660 @default.
• W2062360412 creator A5067067884 @default.
• W2062360412 creator A5068526964 @default.
• W2062360412 creator A5070507248 @default.
• W2062360412 creator A5074158463 @default.
• W2062360412 creator A5076107697 @default.
• W2062360412 creator A5091161682 @default.
• W2062360412 date "2014-12-01" @default.
• W2062360412 modified "2023-09-23" @default.
• W2062360412 title "Hypofractionated stereotactic radiosurgery with concurrent bevacizumab for recurrent malignant gliomas: the University of Alabama at Birmingham experience" @default.
• W2062360412 cites W1990995664 @default.
• W2062360412 cites W2043585381 @default.
• W2062360412 cites W2044538065 @default.
• W2062360412 cites W2051277801 @default.
• W2062360412 cites W2079348899 @default.
• W2062360412 cites W2095365904 @default.
• W2062360412 cites W2096287682 @default.
• W2062360412 cites W2100673960 @default.
• W2062360412 cites W2104352635 @default.
• W2062360412 cites W2133616597 @default.
• W2062360412 cites W2137686302 @default.
• W2062360412 cites W2162643152 @default.
• W2062360412 cites W2170367762 @default.
• W2062360412 doi "https://doi.org/10.1093/nop/npu028" @default.
• W2062360412 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4369713" @default.
• W2062360412 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26034629" @default.
• W2062360412 hasPublicationYear "2014" @default.
• W2062360412 type Work @default.
• W2062360412 sameAs 2062360412 @default.
• W2062360412 citedByCount "13" @default.
• W2062360412 countsByYear W20623604122015 @default.
• W2062360412 countsByYear W20623604122016 @default.
• W2062360412 countsByYear W20623604122017 @default.
• W2062360412 countsByYear W20623604122019 @default.
• W2062360412 countsByYear W20623604122020 @default.
• W2062360412 countsByYear W20623604122021 @default.
• W2062360412 countsByYear W20623604122022 @default.
• W2062360412 countsByYear W20623604122023 @default.
• W2062360412 crossrefType "journal-article" @default.
• W2062360412 hasAuthorship W2062360412A5001717156 @default.
• W2062360412 hasAuthorship W2062360412A5059491130 @default.
• W2062360412 hasAuthorship W2062360412A5064668787 @default.
• W2062360412 hasAuthorship W2062360412A5066841660 @default.
• W2062360412 hasAuthorship W2062360412A5067067884 @default.
• W2062360412 hasAuthorship W2062360412A5068526964 @default.
• W2062360412 hasAuthorship W2062360412A5070507248 @default.
• W2062360412 hasAuthorship W2062360412A5074158463 @default.
• W2062360412 hasAuthorship W2062360412A5076107697 @default.
• W2062360412 hasAuthorship W2062360412A5091161682 @default.
• W2062360412 hasBestOaLocation W20623604121 @default.
• W2062360412 hasConcept C126322002 @default.
• W2062360412 hasConcept C141071460 @default.
• W2062360412 hasConcept C143998085 @default.
• W2062360412 hasConcept C167135981 @default.
• W2062360412 hasConcept C2776694085 @default.
• W2062360412 hasConcept C2777389519 @default.
• W2062360412 hasConcept C2777802072 @default.
• W2062360412 hasConcept C2778227246 @default.
• W2062360412 hasConcept C2780387249 @default.
• W2062360412 hasConcept C2781413609 @default.
• W2062360412 hasConcept C29730261 @default.
• W2062360412 hasConcept C2992393070 @default.
• W2062360412 hasConcept C502942594 @default.
• W2062360412 hasConcept C509974204 @default.
• W2062360412 hasConcept C71924100 @default.
• W2062360412 hasConceptScore W2062360412C126322002 @default.
• W2062360412 hasConceptScore W2062360412C141071460 @default.
• W2062360412 hasConceptScore W2062360412C143998085 @default.
• W2062360412 hasConceptScore W2062360412C167135981 @default.
• W2062360412 hasConceptScore W2062360412C2776694085 @default.
• W2062360412 hasConceptScore W2062360412C2777389519 @default.
• W2062360412 hasConceptScore W2062360412C2777802072 @default.
• W2062360412 hasConceptScore W2062360412C2778227246 @default.
• W2062360412 hasConceptScore W2062360412C2780387249 @default.
• W2062360412 hasConceptScore W2062360412C2781413609 @default.
• W2062360412 hasConceptScore W2062360412C29730261 @default.
• W2062360412 hasConceptScore W2062360412C2992393070 @default.
• W2062360412 hasConceptScore W2062360412C502942594 @default.
• W2062360412 hasConceptScore W2062360412C509974204 @default.
• W2062360412 hasConceptScore W2062360412C71924100 @default.
• W2062360412 hasIssue "4" @default.
• W2062360412 hasLocation W20623604121 @default.
• W2062360412 hasLocation W20623604122 @default.
• W2062360412 hasLocation W20623604123 @default.
• W2062360412 hasLocation W20623604124 @default.
• W2062360412 hasOpenAccess W2062360412 @default.
• W2062360412 hasPrimaryLocation W20623604121 @default.
• W2062360412 hasRelatedWork W165245056 @default.
• W2062360412 hasRelatedWork W1974029597 @default.
• W2062360412 hasRelatedWork W2344666285 @default.
• W2062360412 hasRelatedWork W2358125876 @default.
• W2062360412 hasRelatedWork W2431817062 @default.
• W2062360412 hasRelatedWork W2462822954 @default.

• next